-

Lior Tsviban1, Mordechai R Kramer2,3, Ludmila Fridel2,4

  • 1Pulmonary Institute and Graub CF Center, Schneider Children's Medical Center, Petach Tikva, Israel.

Journal of thoracic disease
|September 15, 2025
PubMed
概括

原生肺阿斯伯吉隆瘤是单个肺移植接受者 (SLTs) 的风险. 早期怀疑和抗真菌疗法为非免疫受损患者提供了类似的预后.